Key result
Genetic risk variants affect ~40-50% of DCM patients and significantly influence SCD risk stratification.
Why the study?
Despite notable advances in understanding dilated cardiomyopathy genetics, a comprehensive mapping of the main research forces, hotspots, and frontiers was needed to shape future research directions.
Systematic Review (n=4,141)
This bibliometric analysis highlights the evolving research landscape of genetics in dilated cardiomyopathy, emphasizing emerging trends in next-generation sequencing, genotype-phenotype correlations, and precision medicine.
Background Dilated cardiomyopathy (DCM) is a heterogeneous myocardial disorder with diverse genetic or acquired origins. Notable advances have been achieved in discovering and understanding the genetics of DCM. This study aimed to depict the distribution of the main research forces, hotspots, and frontiers in the genetics of DCM, thus shaping future research directions. Methods Based on the documents published in the Web of Science Core Collection database from 2013 to 2022, co-authorship of authors, institutions, and countries/regions, co-citation of references, and co-occurrence of keywords were conducted respectively to present the distribution of the leading research forces, research hotspots, and emerging trends in the genetics of DCM. Results 4,141 documents were included, and the annual publications have steadily increased. Seidman, Christine E, Meder, Benjamin, Sinagra, Gianfranco were the most productive authors, German Centre for Cardiovascular Research was the most productive institution, and the USA, China, and Germany were the most prolific countries. The co-occurrence of keywords has generated 8 clusters, including DCM, lamin a/c, heart failure, sudden cardiac death, hypertrophic cardiomyopathy, cardiac hypertrophy, arrhythmogenic cardiomyopathy, and next-generation sequencing. Frequent keywords with average publication time after 2019 mainly included arrhythmogenic cardiomyopathy, whole-exome sequencing, RBM 20, phenotype, risk stratification, precision medicine, genotype, and machine learning. Conclusion The research landscape of genetics in DCM is continuously evolving. Deciphering the genetic profiles by next-generation sequencing and illustrating pathogenic mechanisms of gene variants, establishing innovative treatments for heart failure and improved risk stratification for SCD, uncovering the genetic overlaps between DCM and other inherited cardiomyopathies, as well as identifying genotype-phenotype correlations are the main research hotspots and frontiers in this field.
No takes yet. Share an insight, caveat, or question.
Chao et al. (2024) conducted a systematic review in Dilated cardiomyopathy (DCM) (n=4,141). The research landscape of genetics in dilated cardiomyopathy revealed that genetic risk variants affect approximately 40%-50% of DCM patients, significantly influencing risk stratification for sudden cardiac death.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: